Patents by Inventor Feng-Huei Lin

Feng-Huei Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240122965
    Abstract: A pH-responsive hydrogel, which is synthesized by using mixed pectin and sucralfate treated with a small amount of acid to form a pH-responsive hydrogel. The pH-responsive hydrogel can form a temporary coating on the surface of the gastrointestinal tract to reduce excessive nutrient absorption, and exhibits excellent barrier properties and mucosal adhesion effects, which are useful for reducing blood sugar rise and weight gain, the liver fat accumulation, body fat accumulation and blood low-density lipoprotein that have a significant effect. In addition, the technical principles disclosed in the pH-responsive hydrogel should be applied to other polymer materials to manufacture different pH-responsive hydrogels.
    Type: Application
    Filed: December 5, 2022
    Publication date: April 18, 2024
    Inventors: Feng-Huei LIN, Rui-Chian TANG, Tzu-Chien CHEN
  • Publication number: 20240076797
    Abstract: A susceptor assembly for supporting a crucible during a crystal growth process includes a susceptor base, a tubular sidewall connected to the susceptor base, and a removable sacrifice ring interposed between the susceptor base and the sidewall. Each of the susceptor base and the sidewall is formed of a carbon-containing material. The susceptor base has an annular wall and a shoulder extending radially outward from an outer surface of the annular wall. The sidewall has a first end that receives the annular wall to connect the sidewall to the susceptor base. The sacrifice ring has a first surface that faces the outer surface of the annular wall, a second surface that faces an interior surface of the sidewall, and a ledge extending outward from the second surface that engages the first end of the sidewall.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 7, 2024
    Inventors: Hong-Huei Huang, Benjamin Michael Meyer, Chun-Sheng Wu, Wei-Chen Chou, Chen-Yi Lin, Feng-Chien Tsai
  • Publication number: 20240034979
    Abstract: Provided is a bioreactor apparatus including: a liquid storage chamber for storing a culture medium; a pump for providing pressure to drive the flow of the culture medium; a plurality of culture chambers providing an accommodating space to accommodate the culture medium and a cell to be cultured; and a pipeline connecting the liquid storage chamber, the pump, and the culture chamber to form a closed loop. Also provided is a bioreactor system including the bioreactor apparatus of the present disclosure, the culture medium, and a cell. Further provided is a method for culturing a cell or an organoid by the bioreactor apparatus of the present disclosure. The bioreactor apparatus, bioreactor system, and method of the present disclosure can form a biomimetic circulatory system, which is beneficial for simulating and evaluating the complex microenvironment and physiological mechanism in the living body.
    Type: Application
    Filed: July 26, 2023
    Publication date: February 1, 2024
    Applicant: NATIONAL CENTRAL UNIVERSITY
    Inventors: Ching-Yun CHEN, Feng-Huei LIN, Jui-Sheng SUN, Cherng-Jyh KE, Fu-Chiang YEH, Chun-Yi PENG, Jia-Ci JHANG, Kai-Wei LIN, Qi-Hong HONG, Yu-Syuan DING
  • Publication number: 20230398142
    Abstract: Provided is a method for preventing or treating urological chronic pelvic pain syndrome (UCPPS) in a subject that includes administering an effective amount of cerium oxide nanoparticles (CeNPs) to the subject. Also provided is a method for preventing or treating an UCPPS in a subject that includes administering to the subject a pharmaceutical composition comprising an effective amount of the CeNPs and a pharmaceutically acceptable carrier thereof.
    Type: Application
    Filed: June 8, 2022
    Publication date: December 14, 2023
    Applicants: National Health Research Institutes, National Taiwan University, National Chung Hsing University, National Cheng Kung University
    Inventors: Wei-Chih LIEN, Feng-Huei Lin, Hui-Min Wang, Tak Shing Ching, Xin-Ran Zhou, Ya-Jyun Liang, Chia-Yih Wang, Fu-I Lu, Huei-Cih Chang
  • Publication number: 20230201266
    Abstract: The present disclosure provides a method for treating arthritis by using a stem cell preparation. The stem cell preparation of the present disclosure can effectively delay cartilage degeneration caused by arthritis, and it is confirmed by whole blood analysis and blood biochemical analysis that the stem cell preparation in the form of three-dimensional stem cell spheres provides a safe treatment for arthritis. The present disclosure also provides a method for preparing the stem cell preparation.
    Type: Application
    Filed: September 9, 2021
    Publication date: June 29, 2023
    Inventors: Feng-Huei Lin, Che-Yung Kuan, Yu-Ying Lin, Ching-Yun Chen, Zhi-Yu Chen, I-Hsuan Yang, Ming-Hsi Chuang, Po-Cheng Lin, Chia-Hsin Lee, Kai-Ling Zhang, Pei-Syuan Chao, Wan-Sin Syu, Chun-Hung Chen, Ting-Ju Wang
  • Publication number: 20230131120
    Abstract: The present invention relates to a method for body weight control in a subject in need thereof, comprising administering an effective amount of a thiolated chitosan to the subject. In particular, the thiolated chitosan of the present invention comprises a plurality of thiol groups covalently bonded to a chitosan moiety thereof. The thiolated chitosan of the present invention can be orally administered, which is effective in slowing down body weight gain and has good biocompatibility.
    Type: Application
    Filed: October 24, 2022
    Publication date: April 27, 2023
    Applicant: National Health Research Institutes
    Inventors: Feng-Huei LIN, Ching-Yun Chen
  • Publication number: 20230031385
    Abstract: A corneal storage composition is disclosed. The composition comprises a buffered, balanced, nutrient and electrolyte aqueous solution; ?-PGA; and ferulic acid, in amounts effective to maintain cell integrity and viability of the corneal tissue for a period of greater than 14 days.
    Type: Application
    Filed: July 20, 2021
    Publication date: February 2, 2023
    Inventors: Feng-Huei LIN, Yu-Chun CHEN, Wen-Yu SU, Yen-Hsien LEE, Ko-Hua CHEN
  • Publication number: 20230012279
    Abstract: A hydrogel composition, a hydrogel biomedical material, a method for facilitating regeneration of a bone and a manufacturing method of a hydrogel composition are provided. The hydrogel composition includes a first deionized water, a gel powder, a transglutaminase mixture and a hyaluronic acid powder. The gel powder includes gelatin and alginic acid. The first deionized water, the gel powder, the transglutaminase mixture and the hyaluronic acid powder are evenly mixed. Based on the hydrogel composition being 100 wt %, the first deionized water is 95 wt % to 98.46 wt %, the gel powder is 1 wt % to 3 wt %, the transglutaminase mixture is 0.04 wt % to 0.15 wt %, and the hyaluronic acid powder is 0.5 wt % to 1.5 wt %.
    Type: Application
    Filed: June 30, 2022
    Publication date: January 12, 2023
    Applicant: China Medical University
    Inventors: Cherng-Jyh Ke, Feng-Huei Lin, Chun-Hsu Yao, Jui-Sheng Sun, Ching-Yun Chen
  • Publication number: 20220356434
    Abstract: A magnetic cell biocarrier combined with a powerless bioreactor system comprising a biocarrier, a powerless bioreactor, and a magnetic field device. The biocarrier can detach the cells through temperature regulation and can be adsorbed by the magnetic field device to stabilize at the bottom of the gooseneck cell culture tank; the powerless bioreactor comprises a microinfusion element, a culture fluid collection element, and a gooseneck cell culture tank; the internal space of the gooseneck cell culture tank is interconnected with the microinfusion element and the culture fluid collection element, the microinfusion element slowly injects fresh culture medium When the culture medium in the gooseneck cell culture tank is above an overflow position, the cell metabolites can be automatically discharged to the culture fluid collection element by the interconnected vessels to reduce the risk of cell contamination.
    Type: Application
    Filed: July 21, 2021
    Publication date: November 10, 2022
    Inventors: FENG-HUEI LIN, CHING-YUN CHEN, YUN-YI WANG, YUN-MING WANG
  • Publication number: 20220226672
    Abstract: A focused ultrasound device and method for dermatological treatment. The focused ultrasound device includes a focused ultrasound applicator, an automatic motion mechanism, a driver, a computer, a software operation interface. In addition, the focused ultrasound method for dermatological treatment utilizes the same focused ultrasound applicator, to achieve coaxial deep layer and shallow layer ablation treatment of the skin.
    Type: Application
    Filed: June 10, 2019
    Publication date: July 21, 2022
    Applicant: NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: GIN-SHIN CHEN, FENG-HUEI LIN, JIUN-JUNG CHEN, CHIA-CHING PAN
  • Publication number: 20220118441
    Abstract: Provided herein is a kit for isolation of platelet-rich plasma, comprising a first isolation tube and a second isolation tube. The first isolation tube comprises a first opening and a second opening, and the second isolation tube comprises a first portion, a second portion, and a filter; wherein the first portion has a third opening, the filter is disposed between the first portion and the second portion, the second opening has a diameter in a range of 1 to 5 mm and the filter has a pore size in a range of 1.5 to 4 ?m.
    Type: Application
    Filed: October 15, 2020
    Publication date: April 21, 2022
    Applicant: KARTIGEN BIOMEDICAL INC.
    Inventors: Hwa-Chang Liu, Feng-Huei Lin, Chun-Che Yen
  • Publication number: 20200330114
    Abstract: The present invention discloses an therapeutic ultrasonic device consisting of at least one arc ultrasonic transducer that can be assembled. The arc ultrasonic transducer comprises a protruding part, a concave part and a plurality of piezoelectric vibrating parts. The protruding part and the concave part are disposed at two ends of the arc ultrasonic transducer respectively, and the piezoelectric vibrating parts are disposed at the inner arc face of the arc ultrasonic transducer. Various numbers of arc ultrasonic transducers can be used in assembled structure or non-assembled structure according to different body size and focal zones of various target tissue. Thus the therapeutic ultrasonic device of the present invention is widely used in treatment of various indications.
    Type: Application
    Filed: January 8, 2018
    Publication date: October 22, 2020
    Inventors: Gin-Shin CHEN, Li-Chen CHIU, Jiun-Jung CHEN, Feng-Huei LIN
  • Publication number: 20200308525
    Abstract: A cell culture device comprises a top layer, a diffusion layer, and a suspension layer. The diffusion layer comprises at least one diffusion channel. The suspension layer comprises multiple suspension units. The multiple suspension units are connected to the diffusion channel. A fluid is conducted through the diffusion channel and flow into the suspension units for drop suspended. Cells are cultivated in the fluid suspended in the suspension unit. The cell culture device can be used in an electromagnetic cell culturing system. The electromagnetic cell culturing system is a combination of hanging drop method, microfluidic technology and electromagnetic stimulation. The electromagnetic cell culturing system can improve the growth of cells and also is capable of continuously providing culture medium into the cell culture device. The cell culture device can be used to cultivate large quantity of cells with high productivity and stable quality.
    Type: Application
    Filed: March 12, 2020
    Publication date: October 1, 2020
    Inventors: FENG-HUEI LIN, SHU-WEI HUANG, SHIAN-CHIUAN TZENG, KUO-HSUN TSENG
  • Publication number: 20200197572
    Abstract: The present invention relates to a three-dimensional (3D) tissue-like implant for transplanting to a subject in need comprising a cell cluster comprising mesenchymal stem cells (MSCs) and specific cells differentiated therefrom. The present invention also relate to a method of preparing a 3D-tissue-like implant from MSCs, particularly by seeding MSCs in alginate scaffolds and culturing the alginate scaffolds with MSCs in a 3-D perfusion condition. Further, the present invention provides a method for treating a defect in a recipient patient in need by administering a 3D tissue-like implant as described herein to the patient at a defective site e.g. a bone defective site.
    Type: Application
    Filed: December 24, 2018
    Publication date: June 25, 2020
    Applicant: National Health Research Institutes
    Inventors: Feng-Huei LIN, Jui-Sheng SUN, Ching-Yun CHEN, Chih-Ying CHI
  • Patent number: 10111814
    Abstract: The present invention discloses a desensitizing toothpaste. Based on the total weight of the desensitizing toothpaste, the desensitizing toothpaste includes: from 5% to 40% by weight of DP-bioglass; from 1% to 5% by weight of thickening agents; from 25% to 35% by weight of humectant; and from 1% to 5% by weight of surfactant, wherein the DP-bioglass includes: 8.4% of Na2O, 40.6% of CaO, 39% of SiO2, and 12% of P2O5 based on the total weight of the DP-bioglass. With the implementation of the present invention, the indication of dentin hypersensitivity can be greatly relieved.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: October 30, 2018
    Assignee: NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY
    Inventors: Feng-Huei Lin, Chun-Pin Lin, Chia-Ming Chang, Tzu-Piao Tang, Chung-King Hsu, Hsu-Wei Fang, Hsuan-Yu Chen
  • Patent number: 10066208
    Abstract: The present invention is related to a kit comprising: (a) a mesenchymal stem cell; (b) a gelatin-hyaluronan-chondroitin tri-copolymer scaffold; (c) a kartogenin; and (d) a bioreactor. The present invention is also related to a method for promoting differentiation of a mesenchymal stem cell into cartilage tissue, comprising: (a) culturing the mesenchymal stem cell on a gelatin- hyaluronan-chondroitin tri-copolymer scaffold in the presence of a kartogenin; and (b) culturing the mesenchymal stem cell and the gelatin-hyaluronan-chondroitin tri-copolymer scaffold in a bioreactor.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: September 4, 2018
    Assignee: NATIONAL TAIWAN UNIVERSITY
    Inventors: Feng-Huei Lin, Jui-Sheng Sun, Chunching Li, Ching-Yun Chen, Cherng-Jyh Ke
  • Patent number: 9782385
    Abstract: An artificial tears solution combination is composed mainly of an anti-inflammation and anti-oxidation material, a liquid viscosity-enhancing agent, and an artificial tears solution. The artificial tears solution combination is capable keeping moisture, and meanwhile having anti-inflammation and anti-oxidation capabilities. As such, it can prolong the liquid retention on ocular surfaces, to effective reduce the repeated dosing, and shorten the schedule for the dry eye syndrome.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 10, 2017
    Assignee: NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: Feng-Huei Lin, Hsu-Wei Fang, Ching-Li Tseng, Ya-Jung Hung
  • Patent number: 9662350
    Abstract: A pharmaceutical composition for inhibiting inflammation is provided. The pharmaceutical composition comprises (a) hyaluronic acid, (b) a vitamin and (c) a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: May 30, 2017
    Assignee: CHINA MEDICAL UNIVERSITY
    Inventors: Feng-Huei Lin, Teng-Le Huang, Horng-Chaung Hsu, Chun-Hsu Yao, Yueh-Sheng Chen, Wen-Yu Su
  • Publication number: 20160317491
    Abstract: An artificial tears solution combination is composed mainly of an anti-inflammation and anti-oxidation material, a liquid viscosity-enhancing agent, and an artificial tears solution. The artificial tears solution combination is capable keeping moisture, and meanwhile having anti-inflammation and anti-oxidation capabilities. As such, it can prolong the liquid retention on ocular surfaces, to effective reduce the repeated dosing, and shorten the schedule for the dry eye syndrome.
    Type: Application
    Filed: April 29, 2016
    Publication date: November 3, 2016
    Inventors: Feng-Huei Lin, Hsu-Wei Fang, Ching-Li Tseng, Ya-Jung Hung
  • Patent number: 9457000
    Abstract: Ophthalmic irrigating solutions are disclosed. The ophthalmic irrigating solution comprises: a) ?-polyglutamic acid (?-PGA) and/or salt thereof in an amount effective to increase the viscosity of the irrigating solution, and b) an ophthalmically acceptable aqueous vehicle for the ?-PGA and/or salt thereof. Also disclosed is a method of irrigating ocular tissues of a patient, in which the method comprises introducing to the ocular tissues of the patient an ophthalmic irrigating solution comprising ?-PGA) and/or salt thereof in an amount sufficient to irrigate the ocular tissues of the patient.
    Type: Grant
    Filed: June 16, 2013
    Date of Patent: October 4, 2016
    Assignee: NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: Yu-Chun Chen, Wen-Yu Su, Yen-Hsien Lee, Ko-Hua Chen, Feng-Huei Lin